Non-Polio enterovirus infections cost-effectiveness of therapy
|
Non-Polio enterovirus infections Microchapters |
|
Differentiating Non-Polio enterovirus infections from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Non-Polio enterovirus infections cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Non-Polio enterovirus infections cost-effectiveness of therapy |
|
FDA on Non-Polio enterovirus infections cost-effectiveness of therapy |
|
CDC on Non-Polio enterovirus infections cost-effectiveness of therapy |
|
Non-Polio enterovirus infections cost-effectiveness of therapy in the news |
|
Blogs on Non-Polio enterovirus infections cost-effectiveness of therapy |
|
Directions to Hospitals Treating Non-Polio enterovirus infections |
|
Risk calculators and risk factors for Non-Polio enterovirus infections cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
The health care costs from enterovirus infections are unknown, but a large portion of the costs may come from use of over-the-counter medications to treat symptoms for millions of cases of "summer colds" and "flu" caused by enteroviruses. There are also significant costs associated with the 25,000 to 50,000 hospitalizations for aseptic meningitis each year in the United States.